scholarly journals Endoscopic treatment with self-expanding metal stents for Crohn's disease strictures

2012 ◽  
Vol 36 (9) ◽  
pp. 833-839 ◽  
Author(s):  
C. Loras ◽  
F. Pérez-Roldan ◽  
J. B. Gornals ◽  
J. Barrio ◽  
F. Igea ◽  
...  
2021 ◽  
Vol 8 (1) ◽  
pp. e000612
Author(s):  
Per Hedenström ◽  
Per-Ove Stotzer

ObjectiveFibrotic strictures in the gastrointestinal tract are frequent in Crohn’s disease. Endoscopic dilation is a standard treatment. However, recurrence is common after dilation and there are complications such as bleeding or perforation. Endoscopic treatment using self-expandable metal stents has shown diverging results. The aim of this study was to evaluate the outcome of endoscopic treatment with a self-expandable stent in ileocecal Crohn’s disease.Design/methodPatients with Crohn’s disease and a symptomatic ileocecal stricture were eligible for prospective, consecutive inclusion in a single-centre setting. Patients were randomised to treatment with either 18 mm balloon dilatation (GroupDIL) or stenting (GroupSTENT) using a 20 mm diameter, partially covered Hanarostent NCN. Patients were followed for a minimum of 24 months postendoscopy. Outcomes were technical success, adverse events and clinical success (defined as no need for repeated interventions).ResultsThirteen patients (GroupDIL n=6; GroupSTENT=7) were included with twelve patients (GroupDIL n=5; GroupSTENT=7) being eligible for complete follow-up. Technical success was achieved in all cases. Adverse events were border-line significantly more common in the GroupSTENT: 4/7 (57%) (pain: n=3; pain and rectal bleeding: n=1) compared with the GroupDIL: 0/5 (0%), p=0.08, which resulted in preterm termination of the study. The clinical success rate was GroupSTENT: 6/7 (86%) vs GroupDIL: 1/5 (20%), p=0.07.ConclusionPatients with strictures related to Crohn’s disease may benefit from treatment with self-expandable metal stents rather than dilatation. However, there seems to be an increased risk for patient pain after stenting, which has to be considered and handled.Trail registration numberThe study was registered at Clinical Trials (NCT04718493).


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Clara Yzet ◽  
Franck Brazier ◽  
Charles Sabbagh ◽  
Jean-Philippe Le Mouel ◽  
Sami Hakim ◽  
...  

Author(s):  
Elena Iglesias Jorquera ◽  
Juan Egea Valenzuela ◽  
Andrés Serrano Jiménez ◽  
Gabriel Carrilero Zaragoza ◽  
Antonio Ortega Sabater ◽  
...  

Author(s):  
Julien D Schulberg ◽  
Emily K Wright ◽  
Bronte A Holt ◽  
Helen E Wilding ◽  
Amy L Hamilton ◽  
...  

Author(s):  
Lucía Secondo ◽  
Adrián Canavesi ◽  
Alejandra Arriola ◽  
Nicolás González

A case is presented of a 48-year-old patient, with a 28-year history of Crohn’s disease, with chronic constipation with outlet obstruction symptoms due to the presence of a mucosal bridge at the low rectum. Endoscopic treatment was performed with section of the bridge, without any complications, and with immediate resolution of the symptoms.


Author(s):  
Tatsuya Kikuchi ◽  
Yasushi Yamasaki ◽  
Tsuyoshi Fujimoto ◽  
Shoichi Tanaka

An enterolith in Crohn’s disease is an uncommon but serious condition because it can cause intestinal obstruction. Endoscopic treatment to remove the enterolith is attempted first, but is sometimes difficult owing to poor accessibility of the endoscope. In such cases, surgical treatment is inevitable. We successfully overcame poor accessibility and removed an enterolith using double-balloon enteroscopy. We describe our method below and suggest several helpful techniques.


2006 ◽  
Vol 38 ◽  
pp. S150
Author(s):  
A. Casadei ◽  
D. Valpiani ◽  
C. Cortini ◽  
E. De Vergori ◽  
E. Cavargini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document